News
Rejuvenate Biomed’s newly appointed Clinical Advisory Board endorses Clinical Phase 2b strategy in sarcopenia
Diepenbeek, Belgium, 15 November 2022 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, […] November 15, 2022 · Turnstone CommunicationsIs Belgium becoming a hub for gene therapy?
Ghent, Belgium, 10 November 2022 – Gene therapy provides solutions to deadly diseases. Is the technology ready for a big […] November 10, 2022 · Turnstone CommunicationsIntressa Vascular secures EUR 18 million in financing to support the development of its multilayer Allay™ Aortic Stent for the treatment of aortic dissection
Intressa Vascular is using its proprietary stent braiding technology to develop an innovative multilayer stent for the treatment of aortic […] October 25, 2022 · Turnstone Communications
We need more food and agtech start-ups – and we need them now!
How are we going to feed an expected 10 billion people by 2050 in a sustainable way? It is a […] October 19, 2022 · V-Bio Ventures
V-Bio Ventures leads Sibylla Biotech's EUR 23 million Series A to advance a novel therapeutic approach for undruggable diseases
Ghent, Belgium, 4 October 2022 – V-Bio Ventures announces the successful close of a EUR 23 million Series A financing […] October 4, 2022 · V-Bio VenturesNeuVasQ Appoints Former UCB Ventures VP and Partner Emmanuel Lacroix as Chief Executive Officer and Expands Its Board of Directors
Gosselies, Belgium, 15 September 2022 – NeuVasQ Biotechnologies, a ULB spin-off developing pharmaceuticals to restore blood-brain barrier function, announces the […] September 20, 2022 · Turnstone CommunicationsV-Bio Ventures portfolio company Biodol Therapeutics nominates its first preclinical candidate as a next-generation therapy for neuropathic pain
Ghent, Belgium, 31 August 2022 – V-Bio Ventures portfolio company Biodol Therapeutics, a French biotech company developing next-generation neuropathic pain […] August 31, 2022 · V-Bio VenturesKU Leuven spin-off AstriVax raises € 30 million to build vaccine platform
• Closing on € 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs […] August 25, 2022 · V-Bio VenturesBelgian stakeholders make recommendations for urgently needed data science strategy in healthcare
Antwerp, Belgium, 21 June 2022 – Inovigate, a consulting company for the healthcare industry, together with the Belgian Association of […] June 21, 2022 · Turnstone CommunicationsSpearhead cluster flanders.healthTech turns into MEDVIA and is ready to make a change in healthcare innovation
Ghent, Belgium, 17 May 2022 – With a strong new name and a sleek website, the industry-driven network MEDVIA aims at […] May 17, 2022 · Turnstone Communications
Rejuvenate Biomed appoints life sciences leader Dr. Ajit Shetty as Chair of the Board of Directors to help guide international ambitions
Diepenbeek, Belgium, 12 May 2022 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, appoints […] May 12, 2022 · Turnstone CommunicationsAugustine Therapeutics appoints Gerhard Koenig as Chairman of the Board, forms Clinical Advisory Board, and broadens therapeutic indications
Leuven, Belgium, 10 May 2022 – Augustine Therapeutics, a biotech company developing novel therapies for neuromuscular and neurodegenerative disorders, appoints […] May 10, 2022 · Turnstone Communications
miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test
Leuven, Belgium, 2 May 2022 – miDiagnostics, a fast-growing POC diagnostics company announces the launch of its CE-IVD certified ultra-fast COVID-19 PCR […] May 2, 2022 · Turnstone Communications